Related Experiment Video
Updated: Jun 19, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Expression of hsa-miRNA-15b, -99b, -181a and Their Relationship to Angiogenesis in Renal Cell Carcinoma
József Király1,2, Erzsébet Szabó3,4, Petra Fodor1
1Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Background:
MicroRNAs (miRNAs) play a regulatory role in various human cancers. The roles of hsa-miR-15a-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p have not been fully explored in the angiogenesis of renal cell carcinoma (RCC).
Aims:
The present study aimed to evaluate the expression of these miRNAs in tumorous and adjacent healthy tissues of RCC.
Methods:
Paired tumorous and adjacent normal kidney tissues from 20 patients were studied. The expression levels of hsa-miR-15b-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p were quantified by TaqMan miRNA Assays. Putative targets were analyzed by qRT-PCR.
Results:
Significant downregulation of all three miRNAs investigated was observed in tumorous samples compared to adjacent normal kidney tissues. Spearman analysis showed a negative correlation between the expression levels of miRNAs and the pathological grades of the patients. Increased expression of vascular endothelial growth factor-A (VEGF-A) and hypoxia-inducible factor-1α (HIF-1α), a tissue inhibitor of metalloproteinases-1 (TIMP-1), was observed in tumorous samples compared to adjacent normal tissues. Depletion of tissue inhibitors of metalloproteinase-2 (TIMP-2) and metalloproteinase-2 (MMP-2) was detected compared to normal adjacent tissues. The examined miRNAs might function as contributing factors to renal carcinogenesis. However, more prospective studies are warranted to evaluate the potential role of miRNAs in RCC angiogenesis.
Insights
Three microRNAs (miRNAs) were found to be significantly downregulated in renal cell carcinoma (RCC) tissues compared to normal kidney tissues. This suggests their potential role in kidney cancer development and angiogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are crucial regulators in human cancers.
- The specific roles of hsa-miR-15b-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p in renal cell carcinoma (RCC) angiogenesis remain underexplored.
- Understanding miRNA involvement is key to advancing RCC research.
Purpose of the Study:
- To investigate the expression levels of hsa-miR-15b-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p in both tumorous and adjacent healthy kidney tissues from RCC patients.
- To correlate miRNA expression with pathological grades and key angiogenesis markers.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) using TaqMan miRNA Assays to measure miRNA expression in paired tumor and normal tissues from 20 RCC patients.
- Analysis of putative target gene expression, including VEGF-A, HIF-1α, TIMP-1, TIMP-2, and MMP-2.
Main Results:
- A significant downregulation of hsa-miR-15b-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p was observed in RCC tumor tissues compared to adjacent normal tissues.
- Negative correlation found between miRNA expression levels and RCC pathological grades.
- Elevated expression of pro-angiogenic factors VEGF-A and HIF-1α, along with TIMP-1, and decreased levels of TIMP-2 and MMP-2 were noted in tumor tissues.
Conclusions:
- The studied miRNAs (hsa-miR-15b-5p, hsa-miR-99b-5p, hsa-miR-181a-5p) are significantly downregulated in RCC and may act as tumor suppressors.
- These miRNAs potentially influence renal carcinogenesis by affecting angiogenesis-related factors.
- Further prospective studies are essential to elucidate the precise role of these miRNAs in RCC angiogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
MicroRNAs
lncRNA - Long Non-coding RNAs
Mechanism of Angiogenesis

